The International Association for the Study of Pain says it cannot currently endorse the general use of cannabis and cannabinoids for pain relief based on a lack of high-quality evidence.
California’s Honest Globe, Inc. and Michigan’s BioLyte Laboratories, LLC, have become the latest in a long line of companies to receive official warning letters from the FDA for the illegal marketing of unapproved CBD-containing drugs.
The majority of people with Parkinson’s disease in the United States have not used cannabis to treat their symptoms due to a lack of scientific evidence about its effectiveness, the researchers found.
A synthetic cannabinoid with similar properties to THC can effectively reduce essential tremor in mice, according to a new study from researchers.
The diluent thickener, which is thought to be the culprit behind the outbreak of vaping-related lung injuries seen in the United States in 2019, has been discovered in one of Europe’s most popular CBD vape products.
Given the sheer scale of the country’s CBD sector, it’s likely a THC limit will be drawn up at some point. But what should it be? Well, one group of leading CBD experts have an answer.
With just over two weeks left until its CBD deadline, the FSA has clarified that all novel foods applications just have to be “submitted” by March 31, 2021.
What’s been the environmental cost of the boom in indoor, energy-demanding cannabis farming? A heavy one, according to one new study.
After testing the participants' milk, blood, and urine samples, the study's authors found that all women still had detectable levels of THC in their breastmilk six weeks after quitting cannabis.